{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:17:11Z","timestamp":1790266631309,"version":"4.1.0"},"reference-count":51,"publisher":"Bentham Science Publishers Ltd.","issue":"6","funder":[{"DOI":"10.13039\/501100004515","name":"University Kebangsaan Malaysia through Fundamental Research Grant Scheme","doi-asserted-by":"publisher","award":["FF-2021-206"],"award-info":[{"award-number":["FF-2021-206"]}],"id":[{"id":"10.13039\/501100004515","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Chronic low-grade inflammation is involved in the pathogenesis of postmenopausal osteoporosis, but the cytokines implicated remain elusive.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>This study aimed to compare the difference in cytokine profile between postmenopausal women with and without osteoporosis in Klang Valley, Malaysia.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Postmenopausal women with (n = 20) and without osteoporosis (n = 20) were recruited\nfor this study. Their bone health status was determined using dual-energy X-ray absorptiometry.\nTheir fasting blood was collected for proteomic analysis. A protein array was performed for four\nsubjects randomly selected from each group to screen the potential cytokines. Three cytokines at\nleast 20% different between groups and consistently expressed by each subject were selected for\nvalidation using enzyme-linked immunosorbent assays (ELISA).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The protein array screening demonstrated that platelet-derived growth factor-BB, interleukin-\n6 receptor (IL-6R), and tissue inhibitor of metallopeptidase-2 were higher in women with\nosteoporosis than women without osteoporosis (n = 4 per group), and consistently expressed by\nall women. Only body mass index (BMI)-adjusted logarithmically transformed IL-6R levels were\nlower among postmenopausal women with osteoporosis compared to women with normal bone\nhealth (p = 0.026) (n = 16 per group) in the ELISA test.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>IL-6R was lower among postmenopausal women with osteoporosis compared to women with normal bone health after adjusting for BMI. However, a large-scale epidemiological study with proteomic analysis needs to confirm the findings.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871530323666221114111029","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T04:28:36Z","timestamp":1668572916000},"page":"811-817","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparison of Cytokine Profile between Postmenopausal Women with and\nWithout Osteoporosis \u2013 A Case-Control Study"],"prefix":"10.2174","volume":"23","author":[{"given":"Geok Ting","family":"Soh","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Affaf Hulma","family":"Mohammad","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharifah Nur Liyana","family":"Syed Isa","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kok-Yong","family":"Chin","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norazlina","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.2147\/TCRM.S138000","volume":"14","author":"Pouresmaeili F.","year":"2018","unstructured":"Pouresmaeili F.; Kamali Dehghan B.; Kamarehei M.; Yong M.G.; A comprehensive overview on osteoporosis and its risk factors. Ther Clin Risk Manag 2018,14,2029-2049","journal-title":"Ther Clin Risk Manag"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s12020-021-02806-x","volume":"74","author":"Shevroja E.","year":"2021","unstructured":"Shevroja E.; Cafarelli F.P.; Guglielmi G.; Hans D.; DXA parameters, trabecular bone score (TBS) and bone mineral density (BMD), in fracture risk prediction in endocrine-mediated secondary osteoporosis. Endocrine 2021,74(1),20-28","journal-title":"Endocrine"},{"key":"ref=3","year":"1994","unstructured":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a World Health Organization Study Group. Available from: 1994"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11657-019-0666-2","volume":"14","author":"Subramaniam S.","year":"2019","unstructured":"Subramaniam S.; Chan C.Y.; Soelaiman I.N.; The performance of osteoporosis self-assessment tool for Asians (OSTA) in identifying the risk of osteoporosis among Malaysian population aged 40 years and above. Arch Osteoporos 2019,14(1),117","journal-title":"Arch Osteoporos"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2151459319861591","volume":"10","author":"Carlson B.C.","year":"2019","unstructured":"Carlson B.C.; Robinson W.A.; Wanderman N.R.; A review and clinical perspective of the impact of osteoporosis on the spine. Geriatr Orthop Surg Rehabil 2019,10,1-8","journal-title":"Geriatr Orthop Surg Rehabil"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/os.12605","volume":"12","author":"Zhuang H.","year":"2020","unstructured":"Zhuang H.; Wang P.; Li Y.; Lin J.; Yao X.; Xu H.; Analysis of related factors of brittle hip fracture in postmenopausal women with osteoporosis. Orthop Surg 2020,12(1),194-198","journal-title":"Orthop Surg"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3390\/ijerph17020384","volume":"17","author":"Chan C.Y.","year":"2020","unstructured":"Chan C.Y.; Subramaniam S.; Mohamed N.; Determinants of bone health status in a multi-ethnic population in Klang Valley, Malaysia. Int J Environ Res Public Health 2020,17(2),384","journal-title":"Int J Environ Res Public Health"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.3390\/app9091820","volume":"9","author":"Subramaniam S.","year":"2019","unstructured":"Subramaniam S.; Chan C.Y.; Soelaiman I.N.; Prevalence and predictors of osteoporosis among the Chinese population in Klang Valley, Malaysia. Appl Sci 2019,9(9),1820","journal-title":"Appl Sci"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/9781119266594.ch52","author":"Drake M.T.","year":"2018","unstructured":"Drake M.T.; Khosla S.; Sex steroids and the pathogenesis of osteoporosis. New Jersey: in: Primer on the Metabolic Bone Diseases And Disorders Of Mineral Metabolism 2018,412-418","journal-title":"Primer on the Metabolic Bone Diseases And Disorders Of Mineral Metabolism"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1177\/0004563218759371","volume":"55","author":"Kenkre J.S.","year":"2018","unstructured":"Kenkre J.S.; Bassett J.H.D.; The bone remodelling cycle. Ann Clin Biochem 2018,55(3),308-327","journal-title":"Ann Clin Biochem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/B978-0-12-813073-5.00032-0","author":"Khosla S.","year":"2021","unstructured":"Khosla S.; Pacifici R.; Estrogen deficiency and the pathogenesis of osteoporosis. Marcus and Feldman\u2019s Osteoporosis 2021,773-797","journal-title":"Marcus and Feldman\u2019s Osteoporosis"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.2174\/1871530320666200604160614","volume":"20","author":"Mohamad N.V.","year":"2020","unstructured":"Mohamad N.V.; Ima-Nirwana S.; Chin K.Y.; Are oxidative stress and inflammation mediators of bone loss due to estrogen deficiency? a review of current evidence. Endocr Metab Immune Disord Drug Targets 2020,20(9),1478-1487","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1097\/GME.0000000000000885","volume":"24","author":"Azizieh F.","year":"2017","unstructured":"Azizieh F.; Raghupathy R.; Shehab D.; Al-Jarallah K.; Gupta R.; Cytokine profiles in osteoporosis suggest a proresorptive bias. Menopause 2017,24(9),1057-1064","journal-title":"Menopause"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"e5780","DOI":"10.1097\/MD.0000000000005780","volume":"96","author":"Al-Daghri N.M.","year":"2017","unstructured":"Al-Daghri N.M.; Aziz I.; Yakout S.; Inflammation as a contributing factor among postmenopausal Saudi women with osteoporosis. Medicine 2017,96(4),e5780","journal-title":"Medicine"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.3390\/ijerph17072526","volume":"17","author":"Subramaniam S.","year":"2020","unstructured":"Subramaniam S.; Chan C.Y.; Soelaiman I.N.; Development of osteoporosis screening algorithm for population aged 50 years and above in Klang Valley, Malaysia. Int J Environ Res Public Health 2020,17(7),2526","journal-title":"Int J Environ Res Public Health"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.3390\/ijerph16214115","volume":"16","author":"Chan C.Y.","year":"2019","unstructured":"Chan C.Y.; Subramaniam S.; Chin K.Y.; Levels of knowledge, beliefs, and practices regarding osteoporosis and the associations with bone mineral density among populations more than 40 years old in Malaysia. Int J Environ Res Public Health 2019,16(21),4115","journal-title":"Int J Environ Res Public Health"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nrendo.2017.180","volume":"14","author":"Monteleone P.","year":"2018","unstructured":"Monteleone P.; Mascagni G.; Giannini A.; Genazzani A.R.; Simoncini T.; Symptoms of menopause - global prevalence, physiology and implications. Nat Rev Endocrinol 2018,14(4),199-215","journal-title":"Nat Rev Endocrinol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1189\/jlb.3A0914-430RR","volume":"99","author":"Pelekanou V.","year":"2016","unstructured":"Pelekanou V.; Kampa M.; Kiagiadaki F.; Estrogen anti-inflammatory activity on human monocytes is mediated through cross-talk between estrogen receptor ER&#x3B1;36 and GPR30\/GPER1. J Leukoc Biol 2016,99(2),333-347","journal-title":"J Leukoc Biol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"15224","DOI":"10.1038\/srep15224","volume":"5","author":"Villa A.","year":"2015","unstructured":"Villa A.; Rizzi N.; Vegeto E.; Ciana P.; Maggi A.; Estrogen accelerates the resolution of inflammation in macrophagic cells. Sci Rep 2015,5(1),15224","journal-title":"Sci Rep"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.3390\/ijms19072070","volume":"19","author":"Fischer V.","year":"2018","unstructured":"Fischer V.; Kalbitz M.; M&#xFC;ller-Graf F.; Influence of menopause on inflammatory cytokines during murine and human bone fracture healing. Int J Mol Sci 2018,19(7),2070","journal-title":"Int J Mol Sci"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12916-018-1008-8","volume":"16","author":"Wang Q.","year":"2018","unstructured":"Wang Q.; Ferreira D.L.S.; Nelson S.M.; Sattar N.; Ala-Korpela M.; Lawlor D.A.; Metabolic characterization of menopause: Cross-sectional and longitudinal evidence. BMC Med 2018,16(1),17","journal-title":"BMC Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"687551","DOI":"10.3389\/fimmu.2021.687551","volume":"12","author":"Wu D.","year":"2021","unstructured":"Wu D.; Cline-Smith A.; Shashkova E.; Perla A.; Katyal A.; Aurora R.; T-cell mediated inflammation in postmenopausal osteoporosis. Front Immunol 2021,12,687551","journal-title":"Front Immunol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"e23016","DOI":"10.1002\/jcla.23016","volume":"34","author":"Fang H.","year":"2020","unstructured":"Fang H.; Zhang H.; Wang Z.; Zhou Z.; Li Y.; Lu L.; Systemic immune\u2010inflammation index acts as a novel diagnostic biomarker for postmenopausal osteoporosis and could predict the risk of osteoporotic fracture. J Clin Lab Anal 2020,34(1),e23016","journal-title":"J Clin Lab Anal"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.3892\/mmr.2018.9351","volume":"18","author":"Liu Q.","year":"2018","unstructured":"Liu Q.; Zhou Y.; Li Z.; PDGF-BB promotes the differentiation and proliferation of MC3T3-E1 cells through the Src\/JAK2 signaling pathway. Mol Med Rep 2018,18(4),3719-3726","journal-title":"Mol Med Rep"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/nm.3668","volume":"20","author":"Xie H.","year":"2014","unstructured":"Xie H.; Cui Z.; Wang L.; PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis. Nat Med 2014,20(11),1270-1278","journal-title":"Nat Med"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1210\/endo.134.3.8119182","volume":"134","author":"Hock J.M.","year":"1994","unstructured":"Hock J.M.; Canalis E.; Platelet-derived growth factor enhances bone cell replication, but not differentiated function of osteoblasts. Endocrinology 1994,134(3),1423-1428","journal-title":"Endocrinology"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.2106\/JBJS.G.01231","volume":"90","author":"Hollinger J.O.","year":"2008","unstructured":"Hollinger J.O.; Hart C.E.; Hirsch S.N.; Lynch S.; Friedlaender G.E.; Recombinant human platelet-derived growth factor: biology and clinical applications. J Bone Joint Surg Am 2008,90(S1),48-54","journal-title":"J Bone Joint Surg Am"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1177\/0300060517706630","volume":"45","author":"Tang L.","year":"2017","unstructured":"Tang L.; Xia Z.; Luo Z.; Long H.; Zhu Y.; Zhao S.; Low plasma PDGF-BB levels are associated with estradiol in postmenopausal osteoporosis. J Int Med Res 2017,45(4),1332-1339","journal-title":"J Int Med Res"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/B978-0-12-800134-9.00007-5","author":"Campana L.","year":"2015","unstructured":"Campana L.; Iredale J.; matrix metalloproteinases and their inhibitors. Stellate Cells in Health and Disease 2015,107-124","journal-title":"Stellate Cells in Health and Disease"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.2174\/1381612824666180604112925","volume":"24","author":"Azevedo A.","year":"2018","unstructured":"Azevedo A.; Prado A.F.; Feldman S.; de Figueiredo F.A.T.; dos Santos M.C.G.; Issa J.P.M.; MMPs are involved in osteoporosis and are correlated with cardiovascular diseases. Curr Pharm Des 2018,24(16),1801-1810","journal-title":"Curr Pharm Des"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"e0136797","DOI":"10.1371\/journal.pone.0136797","volume":"10","author":"Valacca C.","year":"2015","unstructured":"Valacca C.; Tassone E.; Mignatti P.; TIMP-2 interaction with MT1-MMP activates the AKT pathway and protects tumor cells from apoptosis. PLoS One 2015,10(9),e0136797","journal-title":"PLoS One"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399403006628","volume":"5","author":"Lafleur M.A.","year":"2003","unstructured":"Lafleur M.A.; Handsley M.M.; Edwards D.R.; Metalloproteinases and their inhibitors in angiogenesis. Expert Rev Mol Med 2003,5(23),1-39","journal-title":"Expert Rev Mol Med"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s007740050091","volume":"17","author":"Shibutani T.","year":"1999","unstructured":"Shibutani T.; Yamashita K.; Aoki T.; Iwayama Y.; Nishikawa T.; Hayakawa T.; Tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) stimulate osteoclastic bone resorption. J Bone Miner Metab 1999,17(4),245-251","journal-title":"J Bone Miner Metab"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1359\/jbmr.2001.16.12.2205","volume":"16","author":"Sobue T.","year":"2001","unstructured":"Sobue T.; Hakeda Y.; Kobayashi Y.; Tissue inhibitor of metalloproteinases 1 and 2 directly stimulate the bone-resorbing activity of isolated mature osteoclasts. J Bone Miner Res 2001,16(12),2205-2214","journal-title":"J Bone Miner Res"},{"key":"ref=35","first-page":"292","volume":"13","author":"Kramer F.J.","year":"2008","unstructured":"Kramer F.J.; Meyer M.; Morgan D.; Tissue inhibitor of metalloproteinases II (TIMP-2) is an osteoanabolic factor in vitro and in vivo. Eur J Med Res 2008,13(6),292-298","journal-title":"Eur J Med Res"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"41411","DOI":"10.1038\/srep41411","volume":"7","author":"Feng W.","year":"2017","unstructured":"Feng W.; Liu H.; Luo T.; Combination of IL-6 and sIL-6R differentially regulate varying levels of RANKL-induced osteoclastogenesis through NF-&#x3BA;B, ERK and JNK signaling pathways. Sci Rep 2017,7(1),41411","journal-title":"Sci Rep"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7150\/ijms.5180","volume":"9","author":"Zhao R.","year":"2012","unstructured":"Zhao R.; Immune regulation of osteoclast function in postmenopausal osteoporosis: A critical interdisciplinary perspective. Int J Med Sci 2012,9(9),825-832","journal-title":"Int J Med Sci"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.7150\/ijbs.4989","volume":"8","author":"Rose-John S.","year":"2012","unstructured":"Rose-John S.; IL-6 trans-signaling via the soluble IL-6 receptor: Importance for the pro-inflammatory activities of IL-6. Int J Biol Sci 2012,8(9),1237-1247","journal-title":"Int J Biol Sci"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/cpt.782","volume":"102","author":"Rose-John S.","year":"2017","unstructured":"Rose-John S.; The soluble interleukin 6 receptor: Advanced therapeutic options in inflammation. Clin Pharmacol Ther 2017,102(4),591-598","journal-title":"Clin Pharmacol Ther"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ejcb.2010.10.007","volume":"90","author":"Chalaris A.","year":"2011","unstructured":"Chalaris A.; Garbers C.; Rabe B.; Rose-John S.; Scheller J.; The soluble Interleukin 6 receptor: Generation and role in inflammation and cancer. Eur J Cell Biol 2011,90(6-7),484-494","journal-title":"Eur J Cell Biol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"11924","DOI":"10.1073\/pnas.90.24.11924","volume":"90","author":"Tamura T.","year":"1993","unstructured":"Tamura T.; Udagawa N.; Takahashi N.; Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci 1993,90(24),11924-11928","journal-title":"Proc Natl Acad Sci"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0531-5565(00)00220-5","volume":"36","author":"Giuliani N.","year":"2001","unstructured":"Giuliani N.; Sansoni P.; Girasole G.; Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes. Exp Gerontol 2001,36(3),547-557","journal-title":"Exp Gerontol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1359\/jbmr.2000.15.8.1545","volume":"15","author":"Abrahamsen B.","year":"2000","unstructured":"Abrahamsen B.; Bonnevie-Nielsen V.; Ebbesen E.N.; Gram J.; Beck-Nielsen H.; Cytokines and bone loss in a 5-year longitudinal study--hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: The danish osteoporosis prevention study. J Bone Miner Res 2000,15(8),1545-1554","journal-title":"J Bone Miner Res"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1359\/jbmr.1998.13.5.777","volume":"13","author":"Nishimura R.","year":"1998","unstructured":"Nishimura R.; Moriyama K.; Yasukawa K.; Mundy G.R.; Yoneda T.; Combination of interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-STAT and MAP kinase pathways in MG-63 human osteoblastic cells. J Bone Miner Res 1998,13(5),777-785","journal-title":"J Bone Miner Res"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"R202","DOI":"10.1186\/ar761","volume":"5","author":"d\u2019Elia H.","year":"2003","unstructured":"d\u2019Elia H.; Mattsson L.&#xC5;.; Ohlsson C.; Nordborg E.; Carlsten H.; Hormone replacement therapy in rheumatoid arthritis is associated with lower serum levels of soluble IL-6 receptor and higher insulin-like growth factor 1. Arthritis Res 2003,5(4),R202-R209","journal-title":"Arthritis Res"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.2147\/DMSO.S275560","volume":"13","author":"Chin K.Y.","year":"2020","unstructured":"Chin K.Y.; Wong S.K.; Ekeuku S.O.; Pang K.L.; Relationship between metabolic syndrome and bone health \u2013 an evaluation of epidemiological studies and mechanisms involved. Diabetes Metab Syndr Obes 2020,13,3667-3690","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3390\/nu8060347","volume":"8","author":"Wong S.","year":"2016","unstructured":"Wong S.; Chin K.Y.; Suhaimi F.; Ahmad F.; Ima-Nirwana S.; The relationship between metabolic syndrome and osteoporosis: A review. Nutrients 2016,8(6),347","journal-title":"Nutrients"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1089\/met.2016.0135","volume":"15","author":"Kuo F.C.","year":"2017","unstructured":"Kuo F.C.; Huang Y.H.; Lin F.H.; Circulating soluble IL-6 receptor concentration and visceral adipocyte size are related to insulin resistance in taiwanese adults with morbid obesity. Metab Syndr Relat Disord 2017,15(4),187-193","journal-title":"Metab Syndr Relat Disord"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"e0133494","DOI":"10.1371\/journal.pone.0133494","volume":"10","author":"Sindhu S.","year":"2015","unstructured":"Sindhu S.; Thomas R.; Shihab P.; Sriraman D.; Behbehani K.; Ahmad R.; Obesity is a positive modulator of IL-6R and IL-6 expression in the subcutaneous adipose tissue: Significance for metabolic inflammation. PloS one 2015,10(7),e0133494","journal-title":"PloS one"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1210\/endo.139.6.6087","volume":"139","author":"Pacifici R.","year":"1998","unstructured":"Pacifici R.; Cytokines, estrogen, and postmenopausal osteoporosis - the second decade. Endocrinology 1998,139(6),2659-2661","journal-title":"Endocrinology"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.cell.2016.10.018","volume":"167","author":"ter Horst R.","year":"2016","unstructured":"ter Horst R.; Jaeger M.; Smeekens S.P.; Host and environmental factors influencing individual human cytokine responses. Cell 2016,167(4),1111-1124.e13","journal-title":"Cell"}],"container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871530323666221114111029","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/210876\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871530323666221114111029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T12:13:19Z","timestamp":1691323999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/210876\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871530323666221114111029","relation":{},"ISSN":["1871-5303"],"issn-type":[{"value":"1871-5303","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-03-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}